$VISM
VISIUM TECHNOLOGIES, INC. Stock $vism

$vism Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000165495424014469 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$370.5K	$508.1K
YoY Change		-27.09%	41.29%
% of Gross Profit
Research & Development		$0.00	$28.36K
YoY Change		-100.0%	-48.33%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$370.5K	$536.5K
YoY Change		-30.95%	29.42%
Operating Profit		-$370.5K	-$536.5K
YoY Change		-30.95%	29.42%
Interest Expense		$54.09K	$46.53K
YoY Change		16.24%	-64.14%
% of Operating Profit
Other Income/Expense, Net		$697.1K	-$52.20K
YoY Change		-1435.51%	-91.63%
Pretax Income		$326.6K	-$588.7K
YoY Change		-155.48%	-43.28%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		$326.6K	-$588.7K
YoY Change		-155.48%	-43.28%
Net Earnings / Revenue
Basic Earnings Per Share		$0.00	-$0.02
Diluted Earnings Per Share		$0.00	-$0.03
COMMON SHARES
Basic Shares Outstanding	242.4M shares	239.5M shares	45.52M shares
Diluted Shares Outstanding		259.2M shares	36.32M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.100K	$30.53K
YoY Change	-73.47%	35.57%
Cash & Equivalents	$8.102K	$30.53K
Short-Term Investments
Other Short-Term Assets		$58.34K
YoY Change		11.12%
Inventory
Prepaid Expenses		$58.34K
Receivables
Other Receivables
Total Short-Term Assets	$8.102K	$88.87K
YoY Change	-90.88%	18.46%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$8.102K	$88.87K
Total Long-Term Assets	$0.00	$0.00
Total Assets	$8.102K	$88.87K
YoY Change	-90.88%	18.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.133M	$1.035M
YoY Change	9.45%	59.94%
Accrued Expenses	$2.349M	$2.065M
YoY Change	13.74%	63.88%
Deferred Revenue
YoY Change
Short-Term Debt	$973.7K	$1.346M
YoY Change	-27.67%	-20.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.710M	$4.705M
YoY Change	0.11%	27.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.710M	$4.705M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$4.710M	$4.705M
YoY Change	0.11%	27.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$62.42M	-$60.94M
YoY Change	2.43%	5.81%
Common Stock	$24.25K	$4.554K
YoY Change	432.52%	1470.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.702M	-$4.616M
YoY Change
Total Liabilities & Shareholders Equity	$8.102K	$88.87K
YoY Change	-90.88%	18.46%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$326.6K	-$588.7K
YoY Change	-155.48%	-43.28%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$110.6K	-$145.7K
YoY Change	-24.1%	-12.99%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$110.2K	$166.3K
YoY Change	-33.69%	-99.69%
NET CHANGE
Cash From Operating Activities	-$110.6K	-$145.7K
Cash From Investing Activities
Cash From Financing Activities	$110.2K	$166.3K
Net Change In Cash	-$355.00	$20.55K
YoY Change	-101.73%	-99.96%
FREE CASH FLOW
Cash From Operating Activities	-$110.6K	-$145.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	vism	Working Capital Deficit WorkingCapitalDeficit	4701680	usd
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	15455	usd
CY2024	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	39637009	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	15282	shares
CY2024	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	11348	shares
CY2024	vism	Incremental Common Shares Attributable To Common Stock Option IncrementalCommonSharesAttributableToCommonStockOption	2222	shares
CY2024	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	5114576	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	259194421	shares
CY2024	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	147141927	shares
CY2024Q3	vism	Conversion Of Accrued Interest ConversionOfAccruedInterest	-3315	usd
CY2024Q3	vism	Interest Expense In Cash InterestExpenseInCash	-3152	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	208198	usd
CY2024Q3	vism	Fair Value Of Shares FairValueOfShares	0.00
CY2024Q3	vism	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term Begining SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermBegining	P1Y7M2D
CY2024Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	0	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q3	vism	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueExercised	0	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q3	vism	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeiture And Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitureAndCancelled	0	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2222	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	27.00
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P1Y7M2D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2222	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	27.00
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2222	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	27.00
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y7M2D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00424
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	17850000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.00424
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001082733
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	242494599	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	213953591	shares
CY2024Q3	vism	Incremental Common Shares Attributable To Common Stock Option IncrementalCommonSharesAttributableToCommonStockOption	2222	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	5114576	shares
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	vism	Derivative Liabilities Fair Value Assumptions Expected Dividend Rate DerivativeLiabilitiesFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q3	vism	Derivative Liabilities Fair Value Assumptions Expected Dividend Rate DerivativeLiabilitiesFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	512542	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	548041	usd
CY2024Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	242394599	shares
CY2023Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	242394599	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023	vism	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Due To Repricing ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedDueToRepricing	5048426	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	242394599	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0	pure
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0	pure
CY2024	vism	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0	pure
CY2023	vism	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2222	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	27.00
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	000-25753
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	VISIUM TECHNOLOGIES, INC.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0449667
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	4094 MAJESTIC LANE
CY2024Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 360
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	FAIRFAX
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22033
CY2024Q3	dei	City Area Code CityAreaCode	703
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	273-0383
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	242394599	shares
CY2024Q3	us-gaap	Cash Cash	8102	usd
CY2024Q2	us-gaap	Cash Cash	8456	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	8102	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	8456	usd
CY2024Q3	us-gaap	Assets Assets	8102	usd
CY2024Q2	us-gaap	Assets Assets	8456	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1132739	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1094516	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2140529	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1986279	usd
CY2024Q3	vism	Due To Officer DueToOfficer	239159	usd
CY2024Q2	vism	Due To Officer DueToOfficer	182633	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	208198	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	540116	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	4523	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	7022	usd
CY2024Q3	vism	Convertible Notes Payable Currents ConvertibleNotesPayableCurrents	288523	usd
CY2024Q2	vism	Convertible Notes Payable Currents ConvertibleNotesPayableCurrents	534361	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	15455	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	41566	usd
CY2024Q3	vism	Discount On Notes Payable DiscountOnNotesPayable	22475	usd
CY2024Q2	vism	Discount On Notes Payable DiscountOnNotesPayable	27126	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	685179	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	777954	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4709782	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5157425	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	242494599	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	213953591	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	24251	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	21397	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57679623	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57561804	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62420874	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62747490	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-4701680	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-5148969	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8102	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8456	usd
CY2024Q3	us-gaap	Revenues Revenues	0	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	370466	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	508140	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28363	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	370466	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	536503	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-370466	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-536503	usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	26111	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-60396	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	725059	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	54730	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	54088	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	46530	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	697082	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-52196	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	326616	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-588699	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	229028045	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36316174	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	259194421	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36316174	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-5148969	usd
CY2024Q3	vism	Shares Issued As Compensation To Directors And Officers Amount SharesIssuedAsCompensationToDirectorsAndOfficersAmount	52500	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	23270	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	44902	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	326616	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-4701680	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4253314	usd
CY2023Q3	vism	Shares Issued As Compensation To Directors And Officers Amount SharesIssuedAsCompensationToDirectorsAndOfficersAmount	62868	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	47351	usd
CY2023Q3	vism	Shares Issued To Employees Amount SharesIssuedToEmployeesAmount	4055	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	111905	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-588699	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	4615834	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	326616	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-588699	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	75770	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	114275	usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	26111	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-60396	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	725059	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	54730	usd
CY2024Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12150	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11235	usd
CY2024Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	42143	usd
CY2023Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	150702	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	58339	usd
CY2024Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	29641	usd
CY2023Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	63201	usd
CY2024Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	154250	usd
CY2023Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	156250	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-110600	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-145709	usd
CY2024Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	56526	usd
CY2023Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	18056	usd
CY2024Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	44250	usd
CY2024Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2023Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	83000	usd
CY2024Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	75000	usd
CY2023Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	135000	usd
CY2024Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	21281	usd
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25548	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	110245	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	166258	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-355	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	20549	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8456	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9982	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8102	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30531	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	3151	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	9541	usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q3	vism	Common Stock Issued For Conversion Of Notes Payable And Accrued Interest CommonStockIssuedForConversionOfNotesPayableAndAccruedInterest	44902	usd
CY2023Q3	vism	Common Stock Issued For Conversion Of Notes Payable And Accrued Interest CommonStockIssuedForConversionOfNotesPayableAndAccruedInterest	111905	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	326616	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-110600	usd
CY2024Q3	us-gaap	Fiscal Period FiscalPeriod	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fiscal year ends on June 30. References to fiscal year 2025, for example, refer to the fiscal year ending June 30, 2025.</p>
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions used in Cox, Ross & Rubinstein Binomial Tree stock-based compensation valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate and in the valuation allowance of deferred tax assets and derivative liability.</p>
CY2024Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is subject to a concentration of credit risk from cash.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s cash account is held at a financial institution and is insured by the Federal Deposit Insurance Corporation, or FDIC, up to $250,000. As of September 30, 2024 and June 30, 2024, the Company did not exceed these FDIC limits.</p>
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	41566	usd
CY2024Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-26111	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	15455	usd
CY2024Q3	vism	Weighted Average Number Of Diluted Shares Outstanding One WeightedAverageNumberOfDilutedSharesOutstandingOne	229028045	shares
CY2024	vism	Weighted Average Number Of Diluted Shares Outstanding One WeightedAverageNumberOfDilutedSharesOutstandingOne	102376772	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	30151094	shares
CY2024Q3	vism	Common Stock Options CommonStockOptions	2222	shares
CY2024Q3	vism	Issuance Of Warrant Shares IssuanceOfWarrantShares	5114576	usd
CY2024Q2	vism	Issuance Of Warrant Shares IssuanceOfWarrantShares	0	usd
CY2024Q3	vism	Antidilutive Securities Excluded From Computation Of Earnings Per Shares AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShares	5116798	shares
CY2024Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	15455	usd
CY2024Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	41566	usd
CY2024Q3	vism	Derivative Liabilities Fair Value Assumptions Exercise Price DerivativeLiabilitiesFairValueAssumptionsExercisePrice	0.00138
CY2023Q3	vism	Derivative Liabilities Fair Value Assumptions Exercise Price DerivativeLiabilitiesFairValueAssumptionsExercisePrice	0.00784
CY2024Q3	vism	Derivative Liabilities Fair Value Assumptions Market Price DerivativeLiabilitiesFairValueAssumptionsMarketPrice	0.0028
CY2023Q3	vism	Derivative Liabilities Fair Value Assumptions Market Price DerivativeLiabilitiesFairValueAssumptionsMarketPrice	0.0252
CY2024Q3	vism	Derivative Liabilities Fair Value Assumptions Expected Volatility Rate DerivativeLiabilitiesFairValueAssumptionsExpectedVolatilityRate	2.7619	pure
CY2023Q3	vism	Derivative Liabilities Fair Value Assumptions Expected Volatility Rate DerivativeLiabilitiesFairValueAssumptionsExpectedVolatilityRate	1.9239	pure
CY2024Q3	vism	Derivative Liabilities Fair Value Assumptions Risk Free Interest Rate DerivativeLiabilitiesFairValueAssumptionsRiskFreeInterestRate	0.0487	pure
CY2023Q3	vism	Derivative Liabilities Fair Value Assumptions Risk Free Interest Rate DerivativeLiabilitiesFairValueAssumptionsRiskFreeInterestRate	0.056	pure
CY2024Q3	vism	Derivative Liabilities Fair Value Assumptions Expected Term DerivativeLiabilitiesFairValueAssumptionsExpectedTerm	P60D
CY2023Q3	vism	Derivative Liabilities Fair Value Assumptions Expected Term DerivativeLiabilitiesFairValueAssumptionsExpectedTerm	P60D
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	41566	usd
CY2024Q3	vism	Loss On Change In Fair Value Of Derivative Liabalities LossOnChangeInFairValueOfDerivativeLiabalities	-26111	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	15455	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	540116	usd
CY2024Q3	vism	Interest Expense Accrued InterestExpenseAccrued	36107	usd
CY2024Q3	us-gaap	Net Investment In Lease Accrued Interest Writeoff NetInvestmentInLeaseAccruedInterestWriteoff	-361559	usd
CY2024Q3	vism	Convertible Notes Payable1 ConvertibleNotesPayable1	293046	usd
CY2024Q2	vism	Convertible Notes Payable1 ConvertibleNotesPayable1	541383	usd
CY2024Q3	vism	Discount On Convertible Notes Payable DiscountOnConvertibleNotesPayable	-4523	usd
CY2024Q2	vism	Discount On Convertible Notes Payable DiscountOnConvertibleNotesPayable	-7022	usd
CY2024Q3	vism	Convertible Notes Payable To Related Parties Current ConvertibleNotesPayableToRelatedPartiesCurrent	288523	usd
CY2024Q2	vism	Convertible Notes Payable To Related Parties Current ConvertibleNotesPayableToRelatedPartiesCurrent	534361	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	288523	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	534361	usd
CY2024Q3	vism	Scheduleofconvertible Notes Payabletabletextblock ScheduleofconvertibleNotesPayabletabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible payable at June 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">534,361</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes issued during the three months ended September 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes repaid in cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Discount amortization related to convertible notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,499</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Write off of convertible note principal balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(208,500 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Conversion of convertible notes payable into common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(39,838 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible payable at September 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">288,523</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	534361	usd
CY2024Q3	vism	Convertible Notes Issued55 ConvertibleNotesIssued55	0	usd
CY2024Q3	vism	Convertible Notes Repaid In Cash ConvertibleNotesRepaidInCash	0	usd
CY2024Q3	vism	Discount Amortization Related To Convertible Notes Payable DiscountAmortizationRelatedToConvertibleNotesPayable	2499	usd
CY2024Q3	vism	Write Off Of Convertible Note Principal Balance WriteOffOfConvertibleNotePrincipalBalance	-208500	usd
CY2024Q3	vism	Conversion Of Convertible Notes Payable Into Common Stock ConversionOfConvertibleNotesPayableIntoCommonStock	-39838	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	288523	usd
CY2024Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	10691000	shares
CY2024Q3	vism	Convertible Notes Payable Principle Amount ConvertibleNotesPayablePrincipleAmount	39838	usd
CY2024Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	3315	usd
CY2024Q3	vism	Convertible Notes Payable Conversion Expense ConvertibleNotesPayableConversionExpense	1750	usd
CY2024Q3	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	44902	usd
CY2024Q3	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.0042
CY2024Q3	vism	Legal Opinion To Extinguish Aged Debt LegalOpinionToExtinguishAgedDebt	725059	usd
CY2024Q3	vism	Accrued Interest Expense AccruedInterestExpense	361559	usd
CY2024Q3	vism	Convertible Note Payable ConvertibleNotePayable	208500	usd
CY2024Q3	vism	Promissory Notes Payable PromissoryNotesPayable	155000	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	725059	usd
CY2023Q3	vism	Common Stock Convertible Conversion Prices Increase CommonStockConvertibleConversionPricesIncrease	0.0169
CY2023Q3	vism	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	66765	usd
CY2024Q3	vism	Loss On Extinguishments Of Debt Related To Payoff Of Convertible Note LossOnExtinguishmentsOfDebtRelatedToPayoffOfConvertibleNote	12035	shares
CY2024Q3	vism	Loss On Extinguishment Of Debt Related To Payoff Of Convertible Note LossOnExtinguishmentOfDebtRelatedToPayoffOfConvertibleNote	-12035	usd
CY2024Q3	vism	Gain On Extinguishment Of Debt Related To Note Conversions GainOnExtinguishmentOfDebtRelatedToNoteConversions	66765	usd
CY2024Q3	vism	Gain On Extinguishment Of Debt Amount GainOnExtinguishmentOfDebtAmount	54730	usd
CY2024Q3	vism	Common Stock Convertible Conversion Prices Increase CommonStockConvertibleConversionPricesIncrease	2.43
CY2024Q3	vism	Increase Number Of Authorized Shares Description IncreaseNumberOfAuthorizedSharesDescription	Common Stock from 1,000,000,000 shares to 3,000,000,000 shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2024Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	242394599	shares
CY2024Q3	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	504925	usd
CY2024Q3	vism	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Due To Repricing ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedDueToRepricing	5048426	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5114576	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.023
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q3	vism	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Warrant ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePriceWarrant	0
CY2024Q3	vism	Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5114716	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0023
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5114576	shares
CY2024Q3	vism	Share Based Compensations Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationsArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.023
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5114576	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y11M1D
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.023
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5114576	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.023
CY2024Q3	vism	Gain Loss On Extinguishment Of Debt Related To Note Conversions GainLossOnExtinguishmentOfDebtRelatedToNoteConversions	725059	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	361559	usd
CY2024Q3	vism	Convertiblenotespayable Write Off ConvertiblenotespayableWriteOff	208500	usd
CY2024Q3	vism	Promissorynotespayable Write Off PromissorynotespayableWriteOff	155000	usd
CY2024Q3	vism	Gain Loss On Extinguishment Of Debt Related To Note Conversions GainLossOnExtinguishmentOfDebtRelatedToNoteConversions	725059	usd
CY2024Q3	vism	Plan Terminates Period PlanTerminatesPeriod	P10Y
CY2024Q3	vism	Options To Purchase Vested Shares OptionsToPurchaseVestedShares	16000000	shares
CY2024Q3	vism	Average Price Per Share Of Stock Option AveragePricePerShareOfStockOption	27.00
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	0	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	0	usd
CY2024Q3	vism	Unrecognized Pre Tax Non Cash Compensation Expense UnrecognizedPreTaxNonCashCompensationExpense	0	usd
CY2024Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2222	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2222	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	27.00
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y7M2D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	17850000	shares
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2140529	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1986279	usd

Files In Submission

Name	View Source	Status
0001654954-24-014469-index-headers.html	Edgar Link	pending
0001654954-24-014469-index.html	Edgar Link	pending
0001654954-24-014469.txt	Edgar Link	pending
0001654954-24-014469-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vism-20240930.xsd	Edgar Link	pending
vism_10q.htm	Edgar Link	pending
vism-20240930_def.xml	Edgar Link	unprocessable
vism-20240930_pre.xml	Edgar Link	unprocessable
vism_10qimg2.jpg	Edgar Link	pending
vism_ex311.htm	Edgar Link	pending
vism_ex312.htm	Edgar Link	pending
vism_ex321.htm	Edgar Link	pending
vism_ex322.htm	Edgar Link	pending
vism_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
vism-20240930_cal.xml	Edgar Link	unprocessable
vism-20240930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VISM
VISIUM TECHNOLOGIES, INC. Stock $vism

2024 Q4 Form 10-Q Financial Statement

#000165495424014469 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VISM VISIUM TECHNOLOGIES, INC. Stock $vism

2024 Q4 Form 10-Q Financial Statement

#000165495424014469 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VISM
VISIUM TECHNOLOGIES, INC. Stock $vism